Chemours Secures $360 M Land Sale for Former Taiwan Titanium Dioxide Site

CCCC

Chemours agreed to sell its remaining titanium dioxide site land in Kuan Yin, Taiwan, to a Century Wind Power–led consortium for roughly $360 million in gross cash proceeds, with closing expected by mid-2026 pending regulatory approval. Chemours will apply the proceeds to reduce its debt obligations.

1. Asset Sale Agreement

The Chemours Company has signed definitive agreements to sell the remaining land at its former titanium dioxide manufacturing site in Kuan Yin, Taiwan to a consortium led by Century Wind Power Co., Ltd., Century Iron & Steel Industrial Co., Ltd. and Century Huaxin Wind Energy, Co., Ltd. The transaction, which follows dismantling and removal activities completed in Q1 2025, is expected to generate gross cash proceeds of approximately $360 million prior to taxes and fees. Local regulatory approvals, including environmental clearances, are anticipated by mid-2026, at which point the deal will substantially close.

2. Impact on Balance Sheet

The $360 million in proceeds will be applied directly to debt reduction, reinforcing Chemours’ commitment to balance-sheet optimization. As of the third quarter of 2025, the company reported total debt of $3.1 billion, representing a leverage ratio of 3.5x EBITDA. Executives expect the sale to lower net debt by roughly 12%, translating into interest savings of approximately $10 million annually based on current borrowing costs.

3. Strategic Portfolio Optimization

This divestiture is part of a broader effort by Chemours to streamline its Titanium Technologies segment and reallocate capital toward higher-margin growth areas within Thermal & Specialized Solutions and Advanced Performance Materials. Management has set a target to reduce non-core asset exposure by $500 million over the next 18 months, and the Taiwan land sale represents over 70% of that goal. The company also plans to reinvest a portion of the freed capital into pilot projects for next-generation refrigerants and specialty fluoropolymers.

4. Outlook and Next Steps

Following the close of the Taiwan land sale, Chemours will update its full-year guidance for 2026 during its Q2 earnings call, currently scheduled for August. Management continues to project adjusted EBITDA growth of 8% to 10% year-over-year, driven by new product launches and ongoing cost-savings initiatives expected to yield $50 million in annualized benefits by year-end. Shareholders will also receive an updated capital allocation plan detailing any incremental share repurchases or dividend adjustments once the sale is finalized.

Sources

ZP